🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.160
-0.020 (-1.69%)
Nov 18, 2026, 1:36 PM EST - Market open

Gain Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.720.8410.3911.797.3136.88
Short-Term Investments
---512.83-
Cash & Short-Term Investments
11.720.8410.3916.7920.1436.88
Cash Growth
32.82%100.64%-38.16%-16.61%-45.40%392.21%
Other Receivables
0.080.80.770.240.190.2
Receivables
0.080.80.770.240.190.2
Prepaid Expenses
0.920.60.450.740.760.65
Total Current Assets
12.722.2411.617.7821.0937.72
Property, Plant & Equipment
0.410.410.320.590.81.01
Long-Term Investments
----1.94-
Other Intangible Assets
0.070.10.130.190.210.2
Other Long-Term Assets
0.060.070.060.050.050.05
Total Assets
13.2322.8212.1218.6124.138.99

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.60.830.951.321.630.56
Accrued Expenses
-2.262.422.1121.4
Current Portion of Long-Term Debt
0.120.10.110.120.110.1
Current Portion of Leases
0.150.120.160.230.230.22
Current Income Taxes Payable
-0.040.020.050.110
Current Unearned Revenue
--0.251.120.060.27
Other Current Liabilities
1.49-----
Total Current Liabilities
2.373.353.914.954.132.55
Long-Term Debt
0.190.30.330.450.50.59
Long-Term Leases
0.220.210.050.230.440.7
Long-Term Unearned Revenue
--0.050.09--
Pension & Post-Retirement Benefits
0.310.390.440.310.160.33
Total Liabilities
3.084.254.786.035.224.17

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
124.07119.1488.7873.1157.3655.83
Retained Earnings
-114.8-101.36-81.19-60.78-38.52-20.93
Comprehensive Income & Other
0.870.78-0.250.250.04-0.09
Total Common Equity
10.1518.567.3412.5818.8834.82
Shareholders' Equity
10.1518.567.3412.5818.8834.82
Total Liabilities & Equity
13.2322.8212.1218.6124.138.99

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.680.730.651.031.271.61
Net Cash (Debt)
11.0220.119.7315.7720.8135.27
Net Cash Growth
34.37%106.57%-38.27%-24.22%-41.01%466.03%
Net Cash Per Share
0.260.610.431.211.753.47
Filing Date Shares Outstanding
44.5342.2427.7916.2211.8811.88
Total Common Shares Outstanding
44.3242.0727.1316.2111.8811.88
Working Capital
10.3318.887.6912.8316.9735.17
Book Value Per Share
0.230.440.270.781.592.93
Tangible Book Value
10.0818.467.2112.3818.6734.61
Tangible Book Value Per Share
0.230.440.270.761.572.91
Machinery
-0.220.20.180.170.12
Leasehold Improvements
-0.040.030.030.030.02
SEC Filings: 10-K · 10-Q